News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Elvina Almuradova: Can We Safely Skip Chemotherapy in HER2+ eBC?
Elvina Almuradova/X
May 16, 2025, 10:30

Elvina Almuradova: Can We Safely Skip Chemotherapy in HER2+ eBC?

Elvina Almuradova, Associate Professor of Oncology at the European Institute of Oncology (IEO), shared a post on X:

“Can we safely skip chemo in HER2+ eBC?
Pooled WSG data show 94% 5y iDFS in pCR patients without systemic chemo.
Favorable markers: PD1, ESR1, Cytotoxic Cells
Unfavorable: PLD1, PPARGC1A
Immune and ERBB2 signals may guide future de-escalation.”

More posts featuring ESMOBreast25.

Breast Cancer cancer chemotherapy Elvina Almuradova ESMOBreast25 OncoDaily Oncology
Special Coverage
Blog
May 16, 2025, 15:04
Elvina Almuradova: Sherene Loi on the Role of Pregnancy and Breastfeeding in Enhancing Early Cancer Detection
Blog
May 16, 2025, 14:53
Tit Albreht Honored with Prestigious Inaugural Award for Improving Cancer Outcomes
Blog
May 16, 2025, 13:31
Anju Aledia: Exploring Science up Close with a Magnifying Glass
Blog
May 16, 2025, 13:24
Amil Družić: The European School of Oncology's Improving Cancer Outcomes and Leadership Course in Zagreb
Oncolibrary
May 16, 2025, 13:21
FDA Approves Retifanlimab-dlwr with Chemotherapy and as Monotherapy for Advanced Squamous Cell Carcinoma of the Anal Canal
Blog
May 16, 2025, 13:01
How Countries are Engaging Stakeholders in the Development and Implementation of NCCPs - Union for International Cancer Control
Oncolibrary
May 16, 2025, 12:59
Eating Well with Mesothelioma: What You Need to Know
Blog
May 16, 2025, 12:54
Douglas Flora: Fantastic Day Connecting with the Incredible Leaders at St. Elizabeth Healthcare
Blog
May 16, 2025, 12:37
Impact of Research Through Maggie’s Lung Cancer Journey - LUNGevity Foundation
Blog
May 16, 2025, 12:28
Giulio Draetta: A $150 million Gift from Kinder Foundation
Science
May 16, 2025, 12:19
Environmental Risk Factors of Wilms Tumour - Childhood Cancer and Leukemia International Consortium
Science
May 16, 2025, 12:17
ROSALINE Trial Reports 49% Response in Lobular Breast Cancer at ESMO 2025